<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>Stroke on GLP-1 指南 — Ozempic、Wegovy、Mounjaro 循证解读</title><link>https://glp1decode.com/zh/tags/stroke/</link><description>Recent content in Stroke on GLP-1 指南 — Ozempic、Wegovy、Mounjaro 循证解读</description><image><title>GLP-1 指南 — Ozempic、Wegovy、Mounjaro 循证解读</title><url>https://glp1decode.com/images/default-og.png</url><link>https://glp1decode.com/images/default-og.png</link></image><generator>Hugo</generator><language>zh</language><lastBuildDate>Tue, 16 Jun 2026 00:00:00 +0000</lastBuildDate><atom:link href="https://glp1decode.com/zh/tags/stroke/index.xml" rel="self" type="application/rss+xml"/><item><title>GLP-1药物与心脏健康：SELECT及其他试验揭示的真相（2026年）</title><link>https://glp1decode.com/zh/posts/glp1-heart-health-cardiovascular-benefits-2026/</link><pubDate>Tue, 16 Jun 2026 00:00:00 +0000</pubDate><guid>https://glp1decode.com/zh/posts/glp1-heart-health-cardiovascular-benefits-2026/</guid><description>GLP-1药物能保护您的心脏吗？深入探讨SELECT试验和其他心血管结局研究——2026年索马鲁肽对心脏病发作、卒中和心血管死亡风险的影响。</description></item></channel></rss>